Active Ingredient(s): Beractant
FDA Approved: * July 1, 1991
Pharm Company: * ROSS LABS
Category: Respiratory Failure

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Survanta Overview

Beractant, also known by the trade name of Survanta, is a modified bovine pulmonary surfactant containing bovine lung extract (phospholipids, neutral lipids, fatty acids, and bovine surfactant proteins), to which synthetic DPPC, tripalmitin and palmitic acid are added. The composition provides 25mg/mL phospholipids, 0.5 to 1.75mg/mL triglycerides, 1.4 to 3.5mg/mL free fatty acids, and [1] As an intratracheal suspension, it can be used for the prevention and treatment of neona...

Read more Survanta Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Survanta Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

  • Suspension: 25mg/ml
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Survanta: (1 result)

Sorted by National Drug Code
  • 0074-1040 Survanta 25 mg/ml Endotracheal Suspension by Abbvie Inc.

Other drugs which contain Beractant or a similar ingredient: (1 result)